Member Info for ShareSting

I hope everyone has a wonderful bank holiday.

As I have invested my hard earned money here I believe there are more positives than negatives. I guess I am
In the majority here !

I don’t get the discount at 76%.

XSG discount = 33%
Prem discount = 20%
SAR discount = 27.3%
HNR discount = 20.9%

What a shocking way to manage a company.
76% discount today when he should have raised at 1p last year. Feel for the long term holders.
I am loading up at 0.25p as the product is good and most of the raise is for ramping up manufacturing.

Anyone complaining about SNG fund raise should see what just happens at TRX. 76% discount !

Thanks for the report Today 15:51 Borsaci06 !

Another strong result sir use of Interferon in the treatment of Covid19.

As we know there are so many variables in Interferon type and dosage, we will have to wait and see what SNG001 delivers, but based on all the data (not our data), this has to be weighted as a success. Hence why we are still all invested and commenting!

Nice to see some blue as well, let’s see if it holds into the close.

Noz85 you wife does an amazing job mate. You should be very proud.

Ghia like you I have a buy order starting with a 4 !
I doubt it will get filled, but you never know.

All coms with the company are rightly now being handled by consilium

Looks like JBER are offloading more now. They will appear later today or tomorrow.

Catch up tomorrow guys. Enjoy the sunshine!

Yes I was to trigger happy and paid 54.5p for today’s 5493
It’s clear JBER continue to tease us with their drip drip.

Looking at the NIHR website it would appear that the Non-hospitalised trials have been added officially on the 11th May.

Patient participation is quite wide. It could be the test has been extended and is up and running and the company are staying quiet. Who can participate:

. Positive virus test for SARS-CoV-2 using RT-PCR or positive point-of-care viral infection test in the presence of strong clinical suspicion of SARS-CoV-2 infection

2. Male or female, =18 years of age at the time of consent

3. Patients admitted to hospital due to the severity of their confirmed or suspected COVID-19 disease OR non-hospitalised patients from high-risk co-morbidity groups such as the >65-years of age, or those with hypertension, cardiovascular disease, diabetes, a chronic lung condition, cancer, or frontline healthcare workers. (The Sponsor will inform sites as to whether non-hospitalised patients are to be entered into the trial).

I agree Nolupus lots of differences.
Why do you think that is ? Can you reach out to Richard or Tim and ask them to explain for us ??

Old news but I like good news stories as they remind us why we are invested. Obviously no one know what he was given.

https://twitter.com/leicesterbrc/status/1263033236751560706?s=21

Looking at the delayed trades from yesterday Most are sells. Lansdowne are still churning their stock out. They must be below 10% by now, would you agree Ghai ?

If they are looking to clear all stock we would need another 10-15 trading days based on current volume.

I’m expecting a few tree shakes this week. I’m surprised there has been no buyer or seller TR1’s. They must be due any day.

It would also appear that my understanding of the medical market is not as broad as I first thought. My comments around conflict of interest were genuine, but it would appear misguided.

Well let’s see what tomorrow brings. I have more funds to add, but waiting for the shake.

Just seemed strange when SNG is running a COPD phase 2 trial which he is involved in and that article announces he is working with Astra Z on a different project looking at COPD.

If I consult to one company, they don’t want me consulting to another looking into a treatment for exactly the same illness.

I took you of filter, as I thought you had become a little more level on your posts. Back on filter now.

Hello all
It looks like everyone is on the golf course today.
Volume is the lowest in months at 405k.

Does anyone see the Prof Tim link with Zeneca a potential conflict of interest?

Well this should be a interesting week ahead.

I’m expecting a TR1 from Lansdowne to land.
I’m also thinking RM will update us on the trials this week. Pure speculation, I should add, but timing feels about right.

We know Synairgen and it’s team are highly respected. They confirmed they had major pharmaceuticals interested in the COPD trials. I would imagine if anything this confirmed discussions have only intensified over the last 3 months.

The company is very good at keeping information in-house, So news updates could land any day.

Sleep well !

The Accord trials didn’t exist when we started our trials.
As I said Prof Tom is heavily involved in both.
This is not a bad thing or a good thing. They are using the SNG template. As GHIA said we are way ahead of this study.

The home trials are also progressing in the background. They have to have everything in place before pressing go.
They can’t start a study and run out of material or not have the right people ready to coordinate the data.

SNG are progressing the drug application paperwork in preparation for positive results. They will file across FDA MHRA and Europe. Data is king. So I am happy the company takes its time.

We are separate to the Accord trials however they are using the SNG template. It is also coordinated by Prof Tom W who is heavily involved with our trials.
The accord trials are around 6-8 weeks behind sng’s.

some interesting comments on here today from so called investors !

LLP great stuff. Synairgen has so much knowledge in this field. They are highly respected around the world. After 15 years of development I’m expecting some fireworks in the lead up to June. (Sorry for being a little rampy today).